Envafolimab drug page Clinical trials

Trials with Envafolimab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

9Trials
3Recruiting
1Countries
1.196Planned patients

Showing 1–3 of 3

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
Recruiting Phase 2 60 patients NCT06321081

This is a non-profit phase II, open, clinical study of the combination of irinotecan plus cetuximab and envafolimab as a rechallenge regimen, in pre-treated RAS/BRAF wild type metastatic colorectal cancer patients (according to liquid biop…

China Mar 2024 – Dec 2026 Interventional
Combined with: CetuximabIrinotecan
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Recruiting Phase 2 198 patients NCT05959356

The primary aim of phase II CEIL study is to evaluate the efficacy of cetuximab and envafolimab plus mFOLFOXIRI versus cetuximab plus mFOLFOX6 as first line treatment of patients with initially unresectable and previously untreated RAS/BRA…

China Nov 2023 – Dec 2028 Interventional
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
Recruiting Phase 3 108 patients NCT05752136

Short-course radiotherapy combined with immunotherapy may bring revolutionary changes to the preoperative neoadjuvant treatment mode for locally advanced rectal cancer.In view of the shortcomings of the current preoperative neoadjuvant tre…

China Apr 2023 – Dec 2028 Interventional

Where the recruiting trials are